日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS

PVRL4 是癌症治疗的分子靶点,其表达受 FOS 转录调控

Tomoyuki Nanamiya #, Kiyoko Takane #, Kiyoshi Yamaguchi, Yuya Okawara, Mariko Arakawa, Akari Saku, Tsuneo Ikenoue, Tomoko Fujiyuki, Misako Yoneda, Chieko Kai, Yoichi Furukawa

Defucosylated Monoclonal Antibody (H(2)Mab-139-mG(2a)-f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2

去岩藻糖基化的单克隆抗体 (H(2)Mab-139-mG(2a)-f) 在小鼠乳腺癌异种移植模型中对人表皮生长因子受体 2 表现出抗肿瘤活性。

Suzuki, Hiroyuki; Ohishi, Tomokazu; Nanamiya, Ren; Kawada, Manabu; Kaneko, Mika K; Kato, Yukinari

yaaJ, the tRNA-Specific Adenosine Deaminase, Is Dispensable in Bacillus subtilis

yaaJ,即tRNA特异性腺苷脱氨酶,在枯草芽孢杆菌中并非必需

Soma, Akiko; Kubota, Atsushi; Tomoe, Daisuke; Ikeuchi, Yoshiho; Kawamura, Fujio; Arimoto, Hijiri; Shiwa, Yuh; Kanesaki, Yu; Nanamiya, Hideaki; Yoshikawa, Hirofumi; Suzuki, Tsutomu; Sekine, Yasuhiko

EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer

EphB4作为奥希替尼对非小细胞肺癌细胞周期进程的EGFR非依赖性抑制作用的新靶点

Nanamiya, Ren; Saito-Koyama, Ryoko; Miki, Yasuhiro; Inoue, Chihiro; Asavasupreechar, Teeranut; Abe, Jiro; Sato, Ikuro; Sasano, Hironobu

Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer

上皮性卵巢癌体细胞致癌突变的鉴定及其临床意义

Watanabe, Takafumi; Nanamiya, Hideaki; Endo, Yuta; Kojima, Manabu; Nomura, Shinji; Furukawa, Shigenori; Soeda, Shu; Tamura, Hirosumi; Ryufuku, Masae; Tanaka, Daisuke; Isogai, Takao; Imai, Jun-Ichi; Watanabe, Shinya; Fujimori, Keiya

Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma

子宫内膜癌中发现的致癌驱动基因突变的临床意义

Watanabe, Takafumi; Nanamiya, Hideaki; Kojima, Manabu; Nomura, Shinji; Furukawa, Shigenori; Soeda, Shu; Tanaka, Daisuke; Isogai, Takao; Imai, Jun-Ichi; Watanabe, Shinya; Fujimori, Keiya

Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma

抗 HER3 单克隆抗体在小鼠结肠直肠腺癌模型中发挥抗肿瘤活性

Teizo Asano, Tomokazu Ohishi, Junko Takei, Takuro Nakamura, Ren Nanamiya, Hideki Hosono, Tomohiro Tanaka, Masato Sano, Hiroyuki Harada, Manabu Kawada, Mika K Kaneko, Yukinari Kato

An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models

抗TROP2单克隆抗体TrMab-6在乳腺癌小鼠异种移植模型中发挥抗肿瘤活性

Tomohiro Tanaka #, Tomokazu Ohishi #, Teizo Asano, Junko Takei, Ren Nanamiya, Hideki Hosono, Masato Sano, Hiroyuki Harada, Manabu Kawada, Mika K Kaneko, Yukinari Kato

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden

肿瘤β-catenin表达与高肿瘤突变负荷的非小细胞肺癌的免疫逃逸相关

Satoshi Muto ,Yuki Ozaki ,Hikaru Yamaguchi ,Hayato Mine ,Hironori Takagi ,Masayuki Watanabe ,Takuya Inoue ,Takumi Yamaura ,Mitsuro Fukuhara ,Naoyuki Okabe ,Yuki Matsumura ,Takeo Hasegawa ,Jun Osugi ,Mika Hoshino ,Mitsunori Higuchi ,Yutaka Shio ,Hideaki Nanamiya ,Jun-Ichi Imai ,Takao Isogai ,Shinya Watanabe ,Hiroyuki Suzuki

Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer

肿瘤突变负担和免疫学、基因组学和临床病理学因素作为非小细胞肺癌患者检查点抑制剂治疗的生物标志物

Yuki Ozaki, Satoshi Muto, Hironori Takagi, Masayuki Watanabe, Takuya Inoue, Mitsuro Fukuhara, Takumi Yamaura, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Ohsugi, Mika Hoshino, Yutaka Shio, Daisuke Tanaka, Hideaki Nanamiya, Jun-Ichi Imai, Takao Isogai, Shinya Watanabe, Hiroyuki Suzuki